| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6488027 | NOVARTIS | Powder inhaler |
Mar, 2019
(5 years ago) | |
| US6887459 | NOVARTIS | Aerosol composition comprising formoterol |
Nov, 2020
(3 years ago) | |
Foradil is owned by Novartis.
Foradil contains Formoterol Fumarate.
Foradil has a total of 2 drug patents out of which 2 drug patents have expired.
Expired drug patents of Foradil are:
- US6488027
- US6887459
Foradil was authorised for market use on 16 February, 2001.
Foradil is available in powder;inhalation dosage forms.
Foradil can be used as treatment of chronic obstructive pulmonary disease.
The generics of Foradil are possible to be released after 28 November, 2020.
Drugs and Companies using FORMOTEROL FUMARATE ingredient
Market Authorisation Date: 16 February, 2001
Treatment: Treatment of chronic obstructive pulmonary disease
Dosage: POWDER;INHALATION
More Information on Dosage
FORADIL family patents
